30389923 |
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
Ip, CKM,
Ng, PKS,
Jeong, KJ,
Shao, SH,
Ju, Z,
Leonard, PG,
Hua, X,
Vellano, CP,
Woessner, R,
Sahni, N,
Scott, KL,
Mills, GB
|
Nat Commun |
2018 |
29093181 |
A precision therapy against cancers driven by KIT/PDGFRA mutations
Evans, EK,
Gardino, AK,
Kim, JL,
Hodous, BL,
Shutes, A,
Davis, A,
Zhu, XJ,
Schmidt-Kittler, O,
Wilson, D,
Wilson, K,
DiPietro, L,
Zhang, Y,
Brooijmans, N,
LaBranche, TP,
Wozniak, A,
Gebreyohannes, YK,
Schöffski, P,
Heinrich, MC,
Deangelo, DJ,
Miller, S,
Wolf, B,
Kohl, N,
Guzi, T,
Lydon, N,
Boral, A,
Lengauer, C
|
Sci Transl Med |
2017 |
19564526 |
Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma
Davids, MS,
Davids, M,
Charlton, A,
Ng, SS,
Chong, ML,
Laubscher, K,
Dar, M,
Hodge, J,
Soong, R,
Goh, BC
|
J. Clin. Oncol. |
2009 |